FDA Warning Letter — NATCO Pharma Limited
The FDA took a Warning Letter action against NATCO Pharma Limited on Apr 8, 2024 (Rangareddy, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- NATCO Pharma Limited
- Date
- Apr 8, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Rangareddy (India)